Argos Therapeutics to Present at BIO CEO & Investor Conference 2007.DURHAM, N.C. -- Argos Therapeutics today announced that John Bonfiglio, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will discuss the Company's dendritic cell-based immunotherapy technology and provide a general corporate overview at the upcoming BIO CEO & Investor conference, to be held at the Waldorf Astoria Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The presentation will begin at 11:15 a.m. (EST) on Tuesday, February 13, 2007, in the Carnegie Suite. Details about the conference, including webcast information, can be found on the conference website at http://www.ceo.bio.org. About Argos Therapeutics, Inc. Argos Therapeutics is developing breakthrough immunotherapies that target the unique features of a patient's disease. This new generation of personalized cancer and infectious disease therapeutics trains the immune system to recognize and attack the disease. Argos' scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform to tackle virtually all forms of cancers and infectious diseases. www.argostherapeutics.com Argos is a private biotechnology company headquartered in Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , NC. The Company has clinical trial programs in cancer and human immunodeficiency virus human immunodeficiency virus n. HIV. Human immunodeficiency virus (HIV) A transmissible retrovirus that causes AIDS in humans. (HIV) and has an ongoing co-development and commercialization alliance with the Pharmaceutical Division of Kirin Brewery Company Kirin Brewery Company, Ltd. (麒麟麦酒株式会社 , Limited. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion